The petcare stocks I’d buy for 2021 and beyond

The petcare industry is booming today. Here, Edward Sheldon highlights sector stocks he’d buy to capitalise on the growth of the industry.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The petcare industry is expanding rapidly today. On the back of rising pet ownership levels and the ‘humanisation’ of our animal friends, the industry is growing at about 6% per year.

For investors, this industry growth is creating some lucrative opportunities. With that in mind, here’s a look at some of my top stock picks in the petcare sector for 2021 and beyond.

UK pet care stocks

Here in the UK, there are a number of petcare stocks listed on the London Stock Exchange. Two names that come to mind are Pets At Home, which is a pet-focused retailer, and CVS Health, which operates vet clinics across the UK.

Both of these companies are growing at a healthy rate right now. However, they don’t strike me as ‘strong buys’. Every time I visit a Pets At Home store, I walk away unimpressed with the offering.

Meanwhile, CVS generates a low return on capital (5.1% last year) and has quite a bit of debt on its balance sheet. All things considered, I think there are better ways to play the petcare boom.

Terry Smith owns this stock

One stock I do like in the space is IDEXX Laboratories (NASDAQ: IDEXX), which is listed in the US. It’s the leading global manufacturer of diagnostic tests for the vet market. IDEXX operates a ‘razor-and-blade’ model with an installed base of about 60,000 systems in vet clinics and reference labs. These systems generate steady recurring revenues because customers are required to continually buy test consumables.

IDEXX is a really impressive company, in my view. Not only does it have a great revenue growth track record (five-year growth of 69%) but it’s also very profitable. Over those last five years, return on capital has averaged 26%, which is excellent. I’m not the only one who’s impressed by this company. Terry Smith (aka ‘Britain’s Warren Buffett’) also likes the stock – currently it’s the third largest position in his Fundsmith fund.

One downside to this stock is that it’s very expensive. Currently, its forward-looking P/E ratio is about 65. This means it’s priced for perfection. I’m comfortable with the risks however, given IDEXX’s dominant position in the industry and high level of profitability.

The Amazon of pet care?

Another petcare stock I’d buy today is Chewy (NYSE: CHWY). This petcare-focused online retailer also operates in the US. Through its website, consumers can purchase pet food and treats, pet supplies, and pet medications.

I see e-commerce and petcare as a great match. Online shopping gives pet owners exactly what they want. Convenience, a wide range of products (food, treats, toys, furniture, etc), product information, and pricing comparisons.

Chewy is growing at a fast pace. For the year ended 31 January, sales rose 47% to $7.1bn. Looking ahead, I expect the company to keep growing rapidly as consumers realise how convenient online shopping for petcare products is. This year, analysts expect the company to generate sales of $8.95bn – growth of around 26%.

One risk to be aware of here is that the company isn’t yet profitable. So, the stock could be volatile in the short term. Competition from rivals such as Amazon is another risk to consider. Overall though, I think this petcare stock has a lot of potential in today’s digital world.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon owns shares in IDEXX Laboratories, Amazon, and London Stock Exchange and has a position in Fundsmith. John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. The Motley Fool UK owns shares of and has recommended Amazon and Idexx Laboratories. The Motley Fool UK has recommended Chewy, Inc and recommends the following options: long January 2022 $1920 calls on Amazon and short January 2022 $1940 calls on Amazon. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »